Skip to main content
search
All Posts By

Kevin Roche

The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry through Roche Consulting, LLC. Mr. Roche is available to assist health care companies through consulting arrangements and may be reached at khroche@healthy-skeptic.com.

Feb 29 2016

Health care management vendor eviCore acquires data mining firm QPID to bolster its analytic capability.

http://www.prnewswire.com/news-releases/leading-technology-enabled-medical-benefit-management-company-evicore-healthcare-acquires-qpid-health-300227090.html
Feb 29 2016

Don't vilify Vivify; the remote patient monitoring company is alive with a fresh $17 million investment round.

http://mobihealthnews.com/content/upmc-leads-17m-investment-vivify-health-its-remote-patient-monitoring-system
Feb 29 2016

To catalyze further growth, data warehousing and analytics vendor Health Catalyst has raised $70 million.

https://www.pehub.com/2016/02/health-catalyst-raises-70-mln/
Feb 26 2016

mcKesson

By Headlines No Comments

McKesson, which owns large oncology practice US Oncology, is buying two more firms in the oncology space for $1.2 billion:  Biologics, a cancer specialty pharmacy; and Vantage Oncology, a radiation and other therapy provider.

Feb 25 2016

Hearst Health Ventures has invested an undisclosed amount into Lightbeam Health Solutions, which collects and analyzes data to aid in identifying high cost patients or episodes.

http://medcitynews.com/2016/02/hearst-health-adds-population-health-to-portfolio/?utm_source=MedCity+News+Subscribers&utm_campaign=8ad03c0606-MCN+Daily+Email&utm_medium=email&utm_term=0_5092836c41-8ad03c0606-408793005&rf=1
Feb 25 2016

Home health condition monitoring firm Healthsense has received an additional $2.5 million in financing.

http://medcitynews.com/2016/02/healthsense-remote-patient-monitroring/?utm_source=MedCity+News+Subscribers&utm_campaign=8ad03c0606-MCN+Daily+Email&utm_medium=email&utm_term=0_5092836c41-8ad03c0606-408793005&rf=1
Feb 23 2016

"Revolutionary" health plan company Oscar has apparently raised $400 million in additional capital at a rumored $2.7 billion valuation.  Fools rush in.

http://www.bloomberg.com/news/articles/2016-02-23/oscar-said-to-be-valued-at-2-7-billion-in-fidelity-led-round?utm_source=hs_email&utm_medium=email&utm_content=26530585&_hsenc=p2ANqtz--Kbvtt7gNc_rS54l4swr9prbJKICNd9cCkMEMbrcvBEE7dNKhYq8nOESbKrMSYNgKTRfYsMZvAUDY1ZzRw8wYUtKXp-1O0wBvcJ8Ufns9296nBJOA&_hsmi=26530585
Feb 22 2016

So you are a health plan selling policies on the reform law insurance exchanges and you do a lousy actuarial and pricing job and you are losing lots of money; so how to fix that.  Let's screw the doctors by cutting their reimbursement 4.5%; that is exactly what Highmark, a Pennsylvania Blues plan is doing.  Gutless, lame, pathetic; call it whatever you want, the regulators should stop it.  It isn't the doctors' fault that Highmark can't price.

http://triblive.com/news/adminpage/10004191-74/highmark-plans-marketplace?utm_medium=nl&utm_source=internal&mkt_tok=3RkMMJWWfF9wsRokuqrPcu%2FhmjTEU5z17e8oXKS2lMI%2F0ER3fOvrPUfGjI4FS8thNa%2BTFAwTG5toziV8R7LMKM1ty9MQWxTk
Close Menu